SE-TK/2023.I./00203 - Kötelező szinten tartó tanfolyam
SE-TK/2023.I./00021 - Szakképzési tanfolyam
SE-TK/2023.I./00204 - Szabadon választható

Időpont: 2023.03.20-28.

Helyszín: 1023 Bp., Frankel Leó út 25-29. OMINT-ORFI Lukács épület, fszt. Közösségi központ

Jelentkezési határidő: 2023.03.19

Kapcsolat: Csonkáné Czibolya Éva
+36202277106
nch@newcongress.hu 

A tanfolyamok adatlapja megtekinthető ide kattintva

Órarend

Why join?
New data from cardiovascular outcomes trials in diabetes have shown that some newer agents have proven CV benefits (e.g. GLP-1 receptor agonists and SGLT2 inhibitors). The compelling evidence has led to significant changes in treatment paradigms as reflected by the new ADA/EASD Consensus Report on the Management of Hyperglycaemia in Type 2 Diabetes.

This highly interactive and skills-based Masterclass will provide an opportunity to discuss the rationale and benefits of new clinical approaches and to share experiences with experts in the field of diabetes management.

Sessions will include:
• Strategies for individualizing therapy
• Applying new diabetes therapies with CV benefit in practice 
• Assessing cardiovascular risk 
• Obesity as a treatable condition 
• Instilling confidence in patients in using injectables 
• New formulations on the horizon

How do I join?
The masterclass is free of charge, travel and accommodation will be provided as appropriate.

To submit an application please visit https://integress.cvent.com/ASCENDMasterclass Places are limited.

Invitation